Luteolin: a natural product with multiple mechanisms for atherosclerosis

Luteolin: a natural product with multiple mechanisms for atherosclerosis

Atherosclerosis (AS) is a degenerative and proliferative disease characterised by the deposition of lipid and/or fibrous substances within the intima of arteries. The pathological mechanisms of AS involve endothelial cell (EC) injury and dysfunction, vascular smooth muscle cell (VSMC) migration and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chanjun Wan, Qingzhi Liang, Yirong Ma, Yang Wang, Liqiang Sun, Junyu Lai, Jianguang Wu, Zhengtao Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Pharmacology
Subjects:	atherosclerosis luteolin pharmacological mechanisms psychological risk factors blood vessel cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1503832/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring the therapeutic mechanisms of heart failure with Chinese herbal medicine: a focus on miRNA-mediated regulation
by: Yang Wang, et al.
Published: (2024-11-01)

Comparative Study of Antiviral Activity of Luteolin and 7,3’-Disulfate Luteolin
by: N. V. Krylova, et al.
Published: (2020-05-01)

Identification of potential molecular targets of luteolin in the treatment of hepatocellular carcinoma based on network pharmacology and transcriptome sequencing technology
by: Yunqi Han, et al.
Published: (2025-08-01)

Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases
by: Jialian Lv, et al.
Published: (2025-02-01)

Mediator effect of luteolin on electrooxidation of NADH
by: Gulshat Gylyjova, et al.
Published: (2021-04-01)

The significance of inflammation in pathogenesis, diagnosis and treatment of atherosclerosis
by: Šačić Dalila, et al.
Published: (2025-01-01)

Virtual Screening of Apigenin and Luteolin as Natural Aromatase Inhibitors for the Treatment of Breast Cancer Patients
by: Baydaa Hamad Obaid Saleh
Published: (2024-10-01)

Physiological and histological effects of apigenin and luteolin on Cytarabine injected rats
by: Ghada A. Taqa, et al.
Published: (2024-01-01)

The bacteriostatic regulation of luteolin from honeysuckle by protein network interaction
by: Jianfeng Zhang, et al.
Published: (2025-08-01)

Extraction, detection, bioactivity, and product development of luteolin: A review
by: Fajian Ren, et al.
Published: (2024-12-01)

Inhibitory effect of luteolin on the metabolism of vandetanib in vivo and in vitro
by: Yuxin Shen, et al.
Published: (2025-03-01)

Exploring the Mechanism of Luteolin in Protecting Chickens from Ammonia Poisoning Based on Proteomic Technology
by: Yu Jin, et al.
Published: (2025-05-01)

Application of PVA hydrogel loaded with luteolin nanoparticles in anti EMT treatment after GBM
by: Long Zhou, et al.
Published: (2025-08-01)

Exploring Therapeutic Potential of Luteolin in Periodontal Therapy: A Scoping Review
by: Premalatha Bidadi Rajashekaraiah, et al.
Published: (2025-06-01)

Optimization of Extraction of Luteolin from <i>Schisandra chinensis</i> by Ionic Liquid–Enzyme Complex System and Antioxidant Study Analysis
by: Jingwei Hao, et al.
Published: (2024-12-01)

Anti-Graying Effects of External and Internal Treatments with Luteolin on Hair in Model Mice
by: Machiko Iida, et al.
Published: (2024-12-01)

Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin in Demyelination, Neurodegeneration, and Epilepsy
by: Mikołaj Grabarczyk, et al.
Published: (2024-11-01)

Identification of luteolin-7-glucoside metabolites after oral administration and development of a method for their quantitative analysis
by: G. V. Adamov, et al.
Published: (2024-09-01)

Structure modification of luteolin and the influence of its derivatives on biological activities
by: Lingyang Kong, et al.
Published: (2025-03-01)

Optimization Method and Stability Test to Determinate Luteolin, Quercetin, Apigenin, and Sinensetin Levels in Herbal Medicines Using TLC-Densitometry
by: Muhammad Hidayatullah, et al.
Published: (2022-12-01)

Luteolin loaded PEGylated cerosomes: a novel treatment for MRSA skin infections
by: Sally A. Mohamed, et al.
Published: (2025-03-01)

Adaptive immunoregulation of luteolin and chlorogenic acid in lipopolysaccharide-induced interleukin-10 expression
by: Chu-Yen Cheng, et al.
Published: (2020-01-01)

aHSCs-targeted bimetallic nanozymes and luteolin-loaded liposomes: Synergistic reversal of liver fibrosis via antioxidant, cellular senescence, and cellular apoptotic mechanisms
by: Zihao Sun, et al.
Published: (2025-10-01)

Luteolin prevents fMLP-induced neutrophils adhesion via suppression of LFA-1 and phosphodiesterase 4 activity
by: Dai-xun JIANG, et al.
Published: (2015-01-01)

Targeting mitophagy in diabetic retinopathy: novel insights into SQSTM1/BNIP3L pathway regulated by luteolin
by: Shuyan Zhang, et al.
Published: (2025-06-01)

Evaluation of Luteolin Nanosuspensions on Pharmacokinetics of Atorvastatin: Drug-Drug Interactions Using Rat Models
by: Liang Y, et al.
Published: (2025-02-01)

PknB and STP as potential targets of luteolin in combating Trueperella pyogenes infections
by: Yueting Guo, et al.
Published: (2025-07-01)

Preclinical evidence for luteolin in ulcerative colitis: a meta-analysis and systematic review
by: Yiyi Feng, et al.
Published: (2025-07-01)

Mechanism of the Traditional Chinese Medicine Simiao Biejia Decoction Improves the Diabetes Mellitus-Induced Erectile Dysfunction in Rats
by: Liu Y, et al.
Published: (2025-04-01)

Luteolin stabilized in nanosheet and cubic γ-cyclodextrin-based metal organic framework for enhanced bioavailability and anti-inflammatory therapy
by: Mubarak G. Bello, et al.
Published: (2025-06-01)

Luteolin attenuates LPS-induced damage in IPEC-J2 cells by enhancing mitophagy via AMPK signaling pathway activation
by: Jianyun Yuan, et al.
Published: (2025-03-01)

Luteolin mitigates hippocampal damage in a rat model of streptozotocin-induced diabetes
by: Omur Gulsum Deniz, et al.
Published: (2025-05-01)

Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities: Insights from In Vitro and In Vivo Studies
by: Muhammad Redza Fahmi Mod Razif, et al.
Published: (2024-10-01)

Targeting Atherosclerosis via NEDD4L Signaling—A Review of the Current Literature
by: Lucas Fornari Laurindo, et al.
Published: (2025-02-01)

Computational analysis of luteolin, apigenin and their derivatives from Allophylus africanus as potential inhibitors of plasmepsin II a malaria target
by: Ismail Abubakari, et al.
Published: (2025-07-01)

The ameliorative effects of honeysuckle extract and its major component luteolin on autism-like behaviors in the NDE1 deficiency model
by: Qi Zhang, et al.
Published: (2025-06-01)

Regulating environmental arsenic-mediated gut-brain toxicity using chitosan-conjugated luteolin gold nanoparticles
by: Ananya Banerjee, et al.
Published: (2025-06-01)

Revealing inhibitory activity of luteolin from Vietnamese Jatropha Podagrica Hook against Staphylococcus aureus by integrating in vitro and in silico approaches
by: Manh Hung Tran, et al.
Published: (2025-08-01)

Luteolin mitigates oxidative stress and multi-organ impairment in a propionic acid-induced rodent model of autism
by: Arwa Ishaq Abdulmalik Khayyat, et al.
Published: (2025-05-01)

Combined treatment of dyslipoproteinemia in patients with atherosclerosis
by: K. K. Mirchuk
Published: (2017-06-01)